Clinical Trial Update: Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin [Phase 2]

View source ↗

Summary

A Phase 2 study comparing the pharmacodynamic effects of lixisenatide versus liraglutide in patients with type 2 diabetes inadequately controlled on insulin gla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lixisenatide (lixisenatide)
• liraglutide (liraglutide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2016-10-14